{"id":"https://openalex.org/W2147015928","doi":"https://doi.org/10.1177/0269881107082944","title":"Asenapine: a novel psychopharmacologic agent with a unique human receptor signature","display_name":"Asenapine: a novel psychopharmacologic agent with a unique human receptor signature","publication_year":2008,"publication_date":"2008-02-28","ids":{"openalex":"https://openalex.org/W2147015928","doi":"https://doi.org/10.1177/0269881107082944","mag":"2147015928","pmid":"https://pubmed.ncbi.nlm.nih.gov/18308814"},"language":"en","primary_location":{"id":"doi:10.1177/0269881107082944","doi":"https://doi.org/10.1177/0269881107082944","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881107082944","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041400343","display_name":"Muhammad Sajjad Shahid","orcid":"https://orcid.org/0000-0002-5137-7698","observed_orcids":["https://orcid.org/0000-0002-5137-7698"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"M. Shahid","raw_affiliation_strings":["Schering-Plough, Newhouse, Lanarkshire, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schering-Plough, Newhouse, Lanarkshire, UK,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113687048","display_name":"GB Walker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"GB Walker","raw_affiliation_strings":["Schering-Plough, Newhouse, Lanarkshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schering-Plough, Newhouse, Lanarkshire, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"SH Zorn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"SH Zorn","raw_affiliation_strings":["Pfizer Global R&D, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113687049","display_name":"EHF Wong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ehf Wong","raw_affiliation_strings":["Pfizer Global R&D, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5041400343"],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":14.9046,"has_fulltext":false,"cited_by_count":499,"citation_normalized_percentile":{"value":0.99440377,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"23","issue":"1","first_page":"65","last_page":"73"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.01769999973475933,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7200000286102295},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.8889999985694885},{"id":"https://openalex.org/keywords/serotonin-receptors","display_name":"serotonin receptors","score":0.7900000214576721},{"id":"https://openalex.org/keywords/dopamine-receptors","display_name":"dopamine receptors","score":0.8220000267028809},{"id":"https://openalex.org/keywords/adrenergic-receptors","display_name":"adrenergic receptors","score":0.8029999732971191},{"id":"https://openalex.org/keywords/histamine-receptors","display_name":"histamine receptors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/muscarinic-receptors","display_name":"muscarinic receptors","score":0.8659999966621399},{"id":"https://openalex.org/keywords/5-ht2c-receptor","display_name":"5-HT2C receptor","score":0.8009999990463257},{"id":"https://openalex.org/keywords/5-ht2a-receptor","display_name":"5-HT2A receptor","score":0.8379999995231628},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.7279999852180481},{"id":"https://openalex.org/keywords/alpha2b-adrenoceptor","display_name":"alpha2B-adrenoceptor","score":0.7630000114440918},{"id":"https://openalex.org/keywords/histamine-h1-receptor","display_name":"histamine H1 receptor","score":0.7409999966621399},{"id":"https://openalex.org/keywords/receptor-antagonism","display_name":"receptor antagonism","score":0.597000002861023},{"id":"https://openalex.org/keywords/receptor-agonism","display_name":"receptor agonism","score":0.531000018119812},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6290000081062317},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.871999979019165},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9599999785423279},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.4749999940395355}],"concepts":[{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6803008317947388},{"id":"https://openalex.org/C2779626651","wikidata":"https://www.wikidata.org/wiki/Q416545","display_name":"Asenapine","level":4,"score":0.6747917532920837},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.5741114616394043},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.5327698588371277},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5167590975761414},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4873424470424652},{"id":"https://openalex.org/C200220013","wikidata":"https://www.wikidata.org/wiki/Q753586","display_name":"5-HT2 receptor","level":5,"score":0.46142011880874634},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.45647722482681274},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3304497003555298},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.30713677406311035},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21402457356452942},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17353641986846924},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16619235277175903},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.1579749882221222},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.07690003514289856}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003001","descriptor_name":"Cloning, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003986","descriptor_name":"Dibenzocycloheptenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006636","descriptor_name":"Histamine Release","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006636","descriptor_name":"Histamine Release","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011941","descriptor_name":"Receptors, Adrenergic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011941","descriptor_name":"Receptors, Adrenergic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011976","descriptor_name":"Receptors, Muscarinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011976","descriptor_name":"Receptors, Muscarinic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/0269881107082944","doi":"https://doi.org/10.1177/0269881107082944","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881107082944","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:18308814","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18308814","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320315018","display_name":"Organon BioSciences","ror":"https://ror.org/02388np20"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W3049811","https://openalex.org/W45776812","https://openalex.org/W162998031","https://openalex.org/W203914688","https://openalex.org/W1550186761","https://openalex.org/W1965124506","https://openalex.org/W1967799255","https://openalex.org/W1984784574","https://openalex.org/W1990664163","https://openalex.org/W1993236628","https://openalex.org/W2006470160","https://openalex.org/W2007907236","https://openalex.org/W2013890548","https://openalex.org/W2014796841","https://openalex.org/W2015302305","https://openalex.org/W2028840707","https://openalex.org/W2036534852","https://openalex.org/W2041474698","https://openalex.org/W2047905218","https://openalex.org/W2052367109","https://openalex.org/W2058553429","https://openalex.org/W2058784065","https://openalex.org/W2064669765","https://openalex.org/W2070357412","https://openalex.org/W2074631079","https://openalex.org/W2077604455","https://openalex.org/W2079939315","https://openalex.org/W2083252023","https://openalex.org/W2086095198","https://openalex.org/W2087350224","https://openalex.org/W2094246063","https://openalex.org/W2094573117","https://openalex.org/W2095213614","https://openalex.org/W2096635847","https://openalex.org/W2119911779","https://openalex.org/W2122995608","https://openalex.org/W2142828574","https://openalex.org/W2156598527","https://openalex.org/W2162395290","https://openalex.org/W2167052106","https://openalex.org/W2290206963","https://openalex.org/W2503799583","https://openalex.org/W4233911645"],"related_works":["https://openalex.org/W7096583220","https://openalex.org/W2103643413","https://openalex.org/W1986343219","https://openalex.org/W1998405751","https://openalex.org/W2361720389","https://openalex.org/W1966220304","https://openalex.org/W4226438855","https://openalex.org/W2074140506","https://openalex.org/W2166214376","https://openalex.org/W2078552955"],"abstract_inverted_index":{"Asenapine":[0,161],"is":[1],"a":[2,55,139,164,221],"novel":[3],"psychopharmacologic":[4],"agent":[5,125],"under":[6,37],"development":[7],"for":[8,63,118,128,142,206,211],"the":[9,20,48,123],"treatment":[10],"of":[11,28,59,155,203,237],"schizophrenia":[12],"and":[13,18,25,30,54,80,90,101,104,109,121,149,193,208,213,229],"bipolar":[14],"disorder.":[15],"We":[16],"determined":[17],"compared":[19],"human":[21,43,223],"receptor":[22,135,224],"binding":[23,60,227],"affinities":[24,61],"functional":[26,198],"characteristics":[27],"asenapine":[29,50,137,219],"several":[31],"antipsychotic":[32,238],"drugs.":[33,239],"Compounds":[34],"were":[35],"tested":[36],"comparable":[38],"assay":[39],"conditions":[40],"using":[41],"cloned":[42],"receptors.":[44,130,196],"In":[45],"comparison":[46],"with":[47,126,226],"antipsychotics,":[49],"showed":[51],"high":[52],"affinity":[53,116,127,141,228],"different":[56],"rank":[57],"order":[58],"(pKi)":[62],"serotonin":[64],"receptors":[65,94,106,120],"(5-HT1A":[66],"[8.6],":[67],"5-HT1B":[68,171],"[8.4],":[69],"5-HT2A":[70,173],"[10.2],":[71],"5-HT2B":[72,175],"[9.8],":[73],"5-HT2C":[74,177],"[10.5],":[75],"5-HT5":[76],"[8.8],":[77],"5-HT6":[78,179],"[9.6]":[79],"5-HT7":[81,181],"[9.9]),":[82],"adrenoceptors":[83],"(alpha1":[84],"[8.9],":[85,87,96,98],"alpha2A":[86,187],"alpha2B":[88,148,189],"[9.5]":[89],"alpha2C":[91,191],"[8.9]),":[92],"dopamine":[93],"(D1":[95],"D2":[97,134,183],"D3":[99,150,185],"[9.4]":[100],"D4":[102],"[9.0])":[103],"histamine":[105],"(H1":[107],"[9.0]":[108],"H2":[110,129],"[8.2]).":[111],"It":[112],"had":[113,138],"much":[114],"lower":[115],"(pKi